The effect of omalizumab treatment on the low affinity immunoglobulin E receptor (CD23/FC epsilon RII) in patients with severe allergic asthma

Miri Assayag, Shabtai Moshel, Martin Kohan, Neville Berkman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'The effect of omalizumab treatment on the low affinity immunoglobulin E receptor (CD23/FC epsilon RII) in patients with severe allergic asthma'. Together they form a unique fingerprint.

Medicine & Life Sciences